AN2 Therapeutics ANTX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.27 | 60 | -14.48 | -9 | -13.08 | 67 |
| 2025Q2 | 1.06 | 69 | -9.09 | -6 | -8.22 | 76 |
| 2025Q1 | 1.36 | 73 | -13.72 | -11 | -12.28 | 81 |
| 2024Q4 | 1.38 | 82 | -8.87 | -8 | -7.93 | 92 |
| 2024Q3 | 1.07 | 88 | -13.70 | -13 | -12.37 | 98 |
| 2024Q2 | 2.15 | 98 | -13.82 | -14 | -12.57 | 108 |
| 2024Q1 | 3.25 | 111 | -14.12 | -17 | -12.78 | 121 |
| 2023Q4 | 20.49 | 125 | -12.82 | -17 | -11.55 | 139 |
| 2023Q3 | 16.08 | 139 | -14.74 | -17 | -13.22 | 154 |
| 2023Q2 | 8.50 | 88 | -18.56 | -16 | -16.63 | 99 |
| 2023Q1 | 9.87 | 83 | -17.23 | -15 | -15.83 | 91 |
| 2022Q4 | 9.53 | 95 | -11.79 | -12 | -11.14 | 103 |
| 2022Q3 | 17.38 | 106 | -10.24 | -11 | -9.86 | 110 |
| 2022Q2 | 7.75 | 116 | -8.75 | -10 | -8.42 | 120 |
| 2022Q1 | 15.07 | 115 | -8 | -8.24 | 121 | |
| 2021Q4 | -47 | -8 | 65 | |||
| 2021Q3 | -7 | |||||
| 2021Q2 | -5 | |||||
| 2021Q1 | -2 | |||||
| 2018Q1 | 53.70 | 27,012 | 4.91 | 1,313 | 1.82 | 73,300 |